A lower frequency of miR-578 and miR-573 overexpression was observed in BRCA1/2-related breast tumors compared to BRCAX breast cancers (0% vs 55%, p=0.018 and 13% vs 55%, p=0.14), respectively. Here, BRCA1 is linked to breast neoplasm.